Scholar Rock Holding (SRRK) Current Assets (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Current Assets came in at $515.3 million in Q1 2026, up 33.75% year-on-year from $385.2 million in Q1 2025, and up 33.79% quarter-over-quarter from $385.1 million in Q4 2025.

Scholar Rock Holding (SRRK) Current Assets (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Current Assets history runs 10 years deep, the most recent figure standing at $515.3 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 33.75% year-over-year to $515.3 million in Q1 2026; TTM through Mar 2026 was $515.3 million, a 33.75% increase from a year earlier, with the FY2025 full-year figure at $385.1 million, down 14.63% from the prior year.
  • Current Assets improved to $515.3 million in Q1 2026 per SRRK's latest filing, from $385.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $515.3 million in Q1 2026 and bottomed at $152.9 million in Q3 2024.
  • The 5-year median for Current Assets is $319.1 million (2025), against an average of $318.4 million.
  • Across the five-year window, Current Assets sank 36.11% in 2023 and jumped 155.49% in 2025, its largest moves.
  • Year by year, Current Assets stood at $328.0 million in 2022, then dropped by 12.14% to $288.2 million in 2023, then jumped by 56.55% to $451.2 million in 2024, then dropped by 14.63% to $385.1 million in 2025, then jumped by 33.79% to $515.3 million in 2026.
  • Per Business Quant, the three latest SRRK Current Assets figures stand at $515.3 million (Q1 2026), $385.1 million (Q4 2025), and $390.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 289.93 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 73.04 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 6.60 Bn
4 NuCana 279.75 Bn 279.75 Bn - 35.73 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 521.86 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 8.07 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.97 Bn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - 515.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 515.28 Mn
Dec 31, 2025 385.15 Mn
Sep 30, 2025 390.71 Mn
Jun 30, 2025 319.13 Mn
Mar 31, 2025 385.25 Mn
Dec 31, 2024 451.17 Mn
Sep 30, 2024 152.93 Mn
Jun 30, 2024 199.14 Mn
Mar 31, 2024 246.93 Mn
Dec 31, 2023 288.19 Mn
Sep 30, 2023 228.47 Mn
Jun 30, 2023 259.81 Mn
Mar 31, 2023 287.16 Mn
Dec 31, 2022 328.02 Mn
Sep 30, 2022 357.61 Mn
Jun 30, 2022 389.14 Mn
Mar 31, 2022 228.59 Mn
Dec 31, 2021 265.32 Mn
Sep 30, 2021 258.16 Mn
Jun 30, 2021 290.37 Mn